PUM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.60860214037939E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.63890000354417E-08 |
Normal-vs-Stage2 |
1.58750000034402E-07 |
Normal-vs-Stage3 |
1.2356782264078E-13 |
Normal-vs-Stage4 |
2.09570139020343E-11 |
Stage1-vs-Stage2 |
1.763630E-01 |
Stage1-vs-Stage3 |
1.519900E-03 |
Stage1-vs-Stage4 |
6.063800E-03 |
Stage2-vs-Stage3 |
3.589800E-01 |
Stage2-vs-Stage4 |
3.985600E-01 |
Stage3-vs-Stage4 |
9.804000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.428280213162E-12 |
Normal-vs-AfricanAmerican |
4.60289995007912E-09 |
Normal-vs-Asian |
4.085800E-01 |
Caucasian-vs-AfricanAmerican |
3.281000E-01 |
Caucasian-vs-Asian |
9.284000E-02 |
AfricanAmerican-vs-Asian |
3.849700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.93776114546063E-12 |
Normal-vs-Female |
9.42609990062238E-10 |
Male-vs-Female |
1.750380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.397380E-04 |
Normal-vs-Age(41-60Yrs) |
7.21980000228939E-08 |
Normal-vs-Age(61-80Yrs) |
1.64190883111814E-12 |
Normal-vs-Age(81-100Yrs) |
2.44779996272371E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.259800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.415600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.429700E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.365710E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.438300E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.880200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.842400E-01 |
Normal-vs-Grade 2 |
3.22200000002493E-06 |
Normal-vs-Grade 3 |
1.62558855265615E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.527640E-01 |
Grade 1-vs-Grade 3 |
1.139300E-03 |
Grade 1-vs-Grade 4 |
4.33560000001609E-06 |
Grade 2-vs-Grade 3 |
1.151070E-04 |
Grade 2-vs-Grade 4 |
3.30710000495671E-08 |
Grade 3-vs-Grade 4 |
1.769830E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.8552000000136E-06 |
Normal-vs-ccB subtype |
2.90945045833269E-12 |
ccA subtype-vs-ccB subtype |
2.22029999999984E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.16760046076081E-10 |
Normal-vs-N1 |
1.398790E-04 |
N0-vs-N1 |
5.763200E-01 |
|
|